We will be discussing our Verisense platform with Kathy Ireland on February 2nd, 8th and 9th.
Be sure to tune in! Until then, here’s a sneak preview!
Where and when to catch us.
Air Date
February 2, 2020
Network and Time
Fox Business Network – 5:30pm EST
as sponsored content
Channel Finder
Air Date
February 8, 2020
Network and Time
Bloomberg EMEA – 7:00pm GMT
Channel Finder
Air Date
February 9, 2020
Network and Time
Bloomberg Latin America – 10:00am CST
Bloomberg Asia Pacific – 2:30pm HKT
Channel Finder
The Product
Our Verisense product offering includes three main components; the Verisense IMU sensor, the Verisense Base Station; and the Verisense Cloud Platform, that all work together seamlessly. Additional sensors, such as ECG, EMG, GSR, PPG, and bio-impedance, will be integrated into the Verisense offering in the near future.
About us
Verisense by Shimmer is a new wearable sensor designed specifically for clinical trials. It allows for continuous remote monitoring of participants’ activity and sleep, with minimum burden on both the participant and the site. It includes a clinical trial management platform with full integration options for sponsors, so you can seamlessly manage your participant data.
How it works
The Verisense IMU sensor records the trial participants’ activity and sleep data onto an in-built flash memory within the sensor. Once this is in range of the base station, an Android device usually placed in the participant’s bedroom, an automated download to the base station begins. This is done via a password protected Bluetooth connection. The base station then performs and automated data upload to the AWS server through a local WiFi or cellular connection.
Contact us.
Interested in learning more about our groundbreaking Verisense® platform?
We’d love to hear from you!